17 results
Lidocaine HCl - sodium channel blocker. Local anesthetic and class 1B antiarrhythmic. Originally developed in 1943
Lidocaine HCl - ... #Pharmacology #Lidocaine ... Xylocaine #Systemic #Review ... #Overview
Guide to Treatment of Hepatitis C with Direct Acting Antivirals.

Here is a pocket guide to initial
of HCV with DAAs ... to the ID board review ... #Management #Pharmacology ... #HepatitisC #HCV ... #Guide #Medications
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
This is an overview ... patients genotype, treatment ... /ambcarerx #HCV ... #Medications #Naming ... Classes #DAAs #Pharmacology
Bupropion HCl - Norepinephrine-Dopamine Reuptake Inhibitor. Atypical antidepressant also used to support smoking cessation. First approved
Bupropion HCl - ... #Pharmacology #Bupropion ... Wellbutrin #Zyban #Overview ... #Review
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Effusion Lymphoma (PEL ... recommended for KS treatment ... PEL: • Chemotherapy ... #Treatment #management ... infections #HIVAIDS #pharmacology
Sulfonamides - Antibiotics Class Overview

BACTRIM/SEPTRA (TMP/SMX) - inhibit sequential steps in Folate synthesis --> bacteriostatic

Spectrum: Wide
Antibiotics Class Overview ... purposes including PCP ... choice, both for treatment ... #Pharmacology #Antibiotics ... #Review #Overview
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS ... Indications for ... #Treatment #opportunistic ... #pharmacology
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
Strep throat in PCN ... Used for MAC treatment ... prophylaxis in HIV ... #Pharmacology #Antibiotics ... #Review #Overview
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
Equina Syndrome Overview ... 33,000-100,000 ppl ... cord infarct • HIV ... bladder for urinary retention ... axial T1 and T2 Treatment
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Inhibitors of Na+K+2Cl ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology ... #Medications #Table